Sonoma Pharmaceuticals (NASDAQ: SNOA) reported Q2 EPS of ($0.32). Revenue for the quarter came in at $5.6 million.

For earnings history and earnings-related data on Sonoma Pharmaceuticals (SNOA) click here.